Arcutis Biotherapeutics Inc. ARQT
$25.29
▼ -0.85% 24H
About
Arcutis Biotherapeutics Inc. is a commercial-stage biopharmaceutical company specializing in medical dermatology treatments for immune-mediated skin diseases. It develops and commercializes innovative topical therapies, with its flagship product ZORYVE (roflumilast) available as a steroid-free cream and foam formulatio…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees354
TickerARQT
Statistics
Market Cap$3.16B
Revenue (TTM)$376.1M
Net Income-$16.1M
Net Margin-4.3%
EPS$-0.13
P/E-189.15
P/S7.05
P/B15.45
EV/EBITDA501.80
ROE-1.4%
Dividend Yield—
Price$25.29
Data: Twelve Data · Revenue = mcap / P/S